Autopsy report · NCT00150085
Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion
Cause of deathNo reason given
Life of this trial
- Registered 1 year 7 months after it had already started.
- Ran for about 1 year 8 months before it stopped.
- 50 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Novartis
- Sponsor type
- Industry
- Conditions
- Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients
- Interventions
- cyclosporine micro-emulsion
- Participants
- 50
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.